These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 730194)

  • 1. Nasopharyngeal carcinoma and histocompatibility antigens.
    Simons MJ; Chan SH; Wee GB; Shanmugaratnam K; Goh EH; Ho JH; Chau JC; Darmalingam S; Prasad U; Betuel H; Day NE; de-The G
    IARC Sci Publ (1971); 1978; (20):271-82. PubMed ID: 730194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunogenetic aspects of nasopharyngeal carcinoma (NPC) III. HL-a type as a genetic marker of NPC predisposition to test the hypothesis that Epstein-Barr virus is an etiological factor in NPC.
    Simons MJ; Wee GB; Chan SH; Shanmugaratnam K; Day NE; de-Thé G
    IARC Sci Publ (1971); 1975; (11 Pt 2):249-58. PubMed ID: 191368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunogenetics of nasopharyngeal carcinoma--position in 1980.
    Chan SH
    Ann Acad Med Singap; 1980 Jul; 9(3):296-9. PubMed ID: 7212610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Correlation between nasopharyngeal carcinoma (NPC) and HLA in Hunan Province].
    Zhang JZ
    Zhonghua Zhong Liu Za Zhi; 1986 May; 8(3):170-2. PubMed ID: 3017660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunogenetic aspects of nasopharyngeal carcinoma. V. Confirmation of a Chinese-related HLA profile (A2, Singapore 2) associated with an increased risk in Chinese for nasopharyngeal carcinoma.
    Simons MJ; Wee GB; Singh D; Dharmalingham S; Yong NK; Chau JC; Ho JH; Day NE; De-Thé G
    Natl Cancer Inst Monogr; 1977 Dec; 47():147-51. PubMed ID: 613233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histocompatibility leukocyte antigen patterns and nasopharyngeal carcinoma.
    Simons MJ; Day NE
    Natl Cancer Inst Monogr; 1977 Dec; 47():143-6. PubMed ID: 613232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Correlation between nasopharyngeal carcinoma and HLA in Sichuan].
    Yuan BW
    Zhonghua Zhong Liu Za Zhi; 1988 Jul; 10(4):263-6. PubMed ID: 3248481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Linkage of a nasopharyngeal carcinoma susceptibility locus to the HLA region.
    Lu SJ; Day NE; Degos L; Lepage V; Wang PC; Chan SH; Simons M; McKnight B; Easton D; Zeng Y
    Nature; 1990 Aug; 346(6283):470-1. PubMed ID: 2377207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA associations with nasopharyngeal carcinoma in Southern Chinese: a meta-analysis.
    Goldsmith DB; West TM; Morton R
    Clin Otolaryngol Allied Sci; 2002 Feb; 27(1):61-7. PubMed ID: 11903375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. General immunological status of nasopharyngeal carcinoma patients in Singapore.
    Chan SH; Goh EH; Khor TH; Chew TS
    IARC Sci Publ (1971); 1978; (20):495-501. PubMed ID: 215531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenetic aspects of nasopharyngeal carcinoma. IV. Increased risk in Chinese of nasopharyngeal carcinoma associated with a Chinese-related HLA profile (A2, Singapore 2).
    Simons MJ; Wee GB; Goh EH; Chan SH; Shanmugaratnam K; Day NE; de-Thé G
    J Natl Cancer Inst; 1976 Nov; 57(5):977-80. PubMed ID: 1003552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HLA and nasopharyngeal carcinoma in Chinese--a further study.
    Chan SH; Day NE; Kunaratnam N; Chia KB; Simons MJ
    Int J Cancer; 1983 Aug; 32(2):171-6. PubMed ID: 6874140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Haplotypes of human leukocyte antigens among patients with nasopharyngeal cancer in Greece.
    Daniilidis M; Fountzilas G; Fleva A; Daniilidis J; Tourkantonis A
    Oncology; 1997; 54(3):185-92. PubMed ID: 9143397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiologic, etiologic and immunologic aspects of nasopharyngeal carcinoma [NPC].
    Gastpar H; Wilmes E; Wolf H
    J Med; 1981; 12(4):257-84. PubMed ID: 6273487
    [No Abstract]   [Full Text] [Related]  

  • 15. HLA and nasopharyngeal carcinoma in Malays.
    Chan SH; Chew CT; Prasad U; Wee GB; Srinivasan N; Kunaratnam N
    Br J Cancer; 1985 Mar; 51(3):389-92. PubMed ID: 3855643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human leukocyte antigen (HLA) frequency among patients with nasopharyngeal carcinoma in Taiwan.
    Wu SB; Hwang SJ; Chang AS; Hsieh T; Hsu MM; Hsieh RP; Chen CJ
    Anticancer Res; 1989; 9(6):1649-53. PubMed ID: 2697183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Apparent correlation between nasopharyngeal carcinoma and HLA phenotype].
    Cui HY
    Zhonghua Zhong Liu Za Zhi; 1982 Nov; 4(4):249-53. PubMed ID: 7166103
    [No Abstract]   [Full Text] [Related]  

  • 18. Associations between human leukocyte antigen type and nasopharyngeal carcinoma in Caucasians in the United States.
    Burt RD; Vaughan TL; McKnight B; Davis S; Beckmann AM; Smith AG; Nisperos B; Swanson GM; Berwick M
    Cancer Epidemiol Biomarkers Prev; 1996 Nov; 5(11):879-87. PubMed ID: 8922295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA-E polymorphism in patients with nasopharyngeal carcinoma.
    Hirankarn N; Kimkong I; Mutirangura A
    Tissue Antigens; 2004 Nov; 64(5):588-92. PubMed ID: 15496202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA and nasopharyngeal cancer.
    Simons MJ; Chan SH; Day NE; Wee GB; Shanmugaratnam K
    Prog Clin Biol Res; 1977; 16():145-8. PubMed ID: 905319
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.